Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease

Respirology

Volumn 18, Issue 8, 2013, Pages 1244-1248

  Wang, Rui Tao ^a   Li, Jia Ying ^a   Cao, Zhi Gang ^a   Li, Ying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

C reactive protein; chronic obstructive pulmonary disease; mean platelet volume; platelet activation; systemic inflammation

Indexed keywords

BRONCHODILATING AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; FIBRINOGEN; HEMOGLOBIN;

ADULT; AGED; ANALYZER; ARTERIAL GAS; ARTICLE; AUTOANALYZER; BLOOD GAS ANALYSIS; BLOOD OXYGEN ANALYZER; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; SMOKING; SPIROMETER; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

C-REACTIVE PROTEIN; CHRONIC OBSTRUCTIVE PULMONARY DISEASE; MEAN PLATELET VOLUME; PLATELET ACTIVATION; SYSTEMIC INFLAMMATION;

AGED; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; FIBRINOGEN; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 84886815668     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12143     Document Type: Article

References (31)

1. Mannino DM, Buist AS,. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773.
2. Sin DD, Wu L, Man SF,. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
3. Guzman-Grenfell A, Nieto-Velazquez N, Torres-Ramos Y, et al. Increased platelet and erythrocyte arginase activity in chronic obstructive pulmonary disease associated with tobacco or wood smoke exposure. J. Investig. Med. 2011; 59: 587-592.
4. Ferroni P, Basili S, Martini F, et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J. Investig. Med. 2000; 48: 21-27.
5. Park Y, Schoene N, Harris W,. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13: 301-306.
6. Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J. Thromb. Haemost. 2010; 8: 148-156.
7. Berger JS, Eraso LH, Xie D, et al. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1999-2004. Atherosclerosis 2010; 213: 586-591.
8. Muscari A, Puddu GM, Cenni A, et al. Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes. Thromb. Res. 2009; 123: 587-591.
9. Kisacik B, Tufan A, Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008; 75: 291-294.
10. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, et al. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol. Int. 2010; 30: 1125-1129.
11. Yuksel O, Helvaci K, Basar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume. Platelets 2009; 20: 277-281.
12. Braekkan SK, Mathiesen EB, Njolstad I, et al. Mean platelet volume is a risk factor for venous thromboembolism: the Tromso Study, Tromso, Norway. J. Thromb. Haemost. 2010; 8: 157-162.
13. Steiropoulos P, Papanas N, Nena E, et al. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities. Angiology 2012. doi: 10.1177/ 0003319712461436
14. Ulasli SS, Ozyurek BA, Yilmaz EB, et al. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease. Pol. Arch. Med. Wewn. 2012; 122: 284-290.
15. Maclay JD, McAllister DA, Johnston S, et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax 2011; 66: 769-774.
16. Varol E, Icli A, Kocyigit S, et al. Effect of smoking cessation on mean platelet volume. Clin. Appl. Thromb. Hemost. 2012; 19: 315-319.
17. Yarlioglues M, Ardic I, Dogdu O, et al. The acute effects of passive smoking on mean platelet volume in healthy volunteers. Angiology 2011; 63: 353-357.
18. Coban E, Ozdogan M, Yazicioglu G, et al. The mean platelet volume in patients with obesity. Int. J. Clin. Pract. 2005; 59: 981-982.
19. Coban E, Yilmaz A, Sari R,. The effect of weight loss on the mean platelet volume in obese patients. Platelets 2007; 18: 212-216.
20. Marin L, Colombo P, Bebawy M, et al. Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management. Expert Opin. Drug Deliv. 2011; 8: 1205-1220.
21. Rodriguez-Roisin R,. Toward a consensus definition for COPD exacerbations. Chest 2000; 117: 398S-401S.
22. Celli BR, MacNee W,. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 2004; 23: 932-946.
23. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580.
24. Wouters EF, Groenewegen KH, Dentener MA, et al. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc. Am. Thorac. Soc. 2007; 4: 626-634.
25. Chuen CK, Li K, Yang M, et al. Interleukin-1beta up-regulates the expression of thrombopoietin and transcription factors c-Jun, c-Fos, GATA-1, and NF-E2 in megakaryocytic cells. J. Lab. Clin. Med. 2004; 143: 75-88.
26. Wedzicha JA, Syndercombe-Court D, Tan KC,. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxaemia. Thorax 1991; 46: 504-507.
27. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr. Pharm. Des. 2011; 17: 47-58.
28. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann. Intern. Med. 2005; 142: 233-239.
29. Pauwels RA, Lofdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N. Engl. J. Med. 1999; 340: 1948-1953.
30. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331-342.
31. Gawaz M, Langer H, May AE,. Platelets in inflammation and atherogenesis. J. Clin. Invest. 2005; 115: 3378-3384.